Advertisement

May 2015 Briefing – Pathology

0
Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2015. This roundup includes the latest...
Low physician spending is contributing to an overall slowing of health care costs

AMA: Physicians Driving the Slowing of Health Care Costs

0
Physicians' spending grew more slowly over 2003 to 2013 than hospital and clinical spending
Patients with HIV should start antiretroviral therapy as soon as they're diagnosed

Greater Benefit for Early Antiretroviral Tx Initiation in HIV

0
NIH-funded trial results appear likely to impact global treatment guidelines
Population-based fecal immunochemical testing screening in adults aged 50 to 69 years can reduce colorectal cancer mortality

Population-Based FIT Screening Can Reduce CRC Mortality

0
Large cohort study shows significant reduction among screened 50- to 69-year-olds in Taiwan
Among older adults

Specific Trans Fatty Acids Linked With Incident Diabetes

0
Correlations differ by specific trans fatty acid and by method of assessment
Copy number variations correlate with phenotypes such as intellectual disability in the general population

Genetic Variants Linked to Educational Attainment

0
CNVs linked to lower education attainment in geographically distinct unselected populations
Adhering to a Mediterranean diet may significantly reduce a woman's risk of endometrial cancer

Mediterranean Diet Might Lower Endometrial Cancer Risk

0
Women who followed it most closely saw significant reduction in risk
Between 1990 and 2013

14.9 Million New Cancer Cases Worldwide in 2013

0
Cancer is now second leading cause of death after cardiovascular disease
Many patients with cancer are interested in comprehensive tumor genetic profiling (CGP)

ASCO: Many Cancer Patients Interested in Genetic Profiling

0
Two-thirds of patients feel that tumor profiling could improve their treatment; many will pay out of pocket
A genetically engineered form of the herpes virus is showing promise in slowing the progression of melanoma

HSV-Derived Immunotherapy Promising in Advanced Melanoma

0
Study shows it helped a minority of patients, and experts say this approach has promise